Mohanraj Ramachandran
Researcher at Department of Immunology, Genetics and Pathology; Research programme: Cancer Immunotherapy; Research group Magnus Essand
- E-mail:
- mohanraj.ramachandran@igp.uu.se
- Visiting address:
- Dag Hammarskjölds väg 20
751 85 Uppsala - Postal address:
- Rudbecklaboratoriet
751 85 UPPSALA
Researcher at Department of Immunology, Genetics and Pathology; Research programme: Vascular Biology; Research group Anna Dimberg
- E-mail:
- mohanraj.ramachandran@igp.uu.se
- Visiting address:
- Dag Hammarskjölds väg 20
751 85 Uppsala - Postal address:
- Rudbecklaboratoriet
751 85 UPPSALA

Publications
Recent publications
-
Part of Molecular Cancer Therapeutics, p. 469-479, 2026
- DOI for Shaping Tumor Microenvironment by Amplifying the Complement Cascade for Improved Immune Response in Pancreatic Cancer Model
- Download full text (pdf) of Shaping Tumor Microenvironment by Amplifying the Complement Cascade for Improved Immune Response in Pancreatic Cancer Model
-
Part of Journal for ImmunoTherapy of Cancer, 2025
- DOI for Brain tumors induce immunoregulatory dendritic cells in draining lymph nodes that can be targeted by OX40 agonist treatment
- Download full text (pdf) of Brain tumors induce immunoregulatory dendritic cells in draining lymph nodes that can be targeted by OX40 agonist treatment
-
Lack of ST2 aggravates glioma invasiveness, vascular abnormality, and immune suppression
Part of Neuro-Oncology Advances, 2025
- DOI for Lack of ST2 aggravates glioma invasiveness, vascular abnormality, and immune suppression
- Download full text (pdf) of Lack of ST2 aggravates glioma invasiveness, vascular abnormality, and immune suppression
-
Immunotherapy for Neuroendocrine Neoplasms
Part of Neuroendocrine Tumours, p. 665-676, Springer Nature, 2024
-
VLDLR mediates Semliki Forest virus neuroinvasion through the blood-cerebrospinal fluid barrier
Part of Nature Communications, 2024
- DOI for VLDLR mediates Semliki Forest virus neuroinvasion through the blood-cerebrospinal fluid barrier
- Download full text (pdf) of VLDLR mediates Semliki Forest virus neuroinvasion through the blood-cerebrospinal fluid barrier
All publications
Articles in journal
-
Part of Molecular Cancer Therapeutics, p. 469-479, 2026
- DOI for Shaping Tumor Microenvironment by Amplifying the Complement Cascade for Improved Immune Response in Pancreatic Cancer Model
- Download full text (pdf) of Shaping Tumor Microenvironment by Amplifying the Complement Cascade for Improved Immune Response in Pancreatic Cancer Model
-
Part of Journal for ImmunoTherapy of Cancer, 2025
- DOI for Brain tumors induce immunoregulatory dendritic cells in draining lymph nodes that can be targeted by OX40 agonist treatment
- Download full text (pdf) of Brain tumors induce immunoregulatory dendritic cells in draining lymph nodes that can be targeted by OX40 agonist treatment
-
Lack of ST2 aggravates glioma invasiveness, vascular abnormality, and immune suppression
Part of Neuro-Oncology Advances, 2025
- DOI for Lack of ST2 aggravates glioma invasiveness, vascular abnormality, and immune suppression
- Download full text (pdf) of Lack of ST2 aggravates glioma invasiveness, vascular abnormality, and immune suppression
-
VLDLR mediates Semliki Forest virus neuroinvasion through the blood-cerebrospinal fluid barrier
Part of Nature Communications, 2024
- DOI for VLDLR mediates Semliki Forest virus neuroinvasion through the blood-cerebrospinal fluid barrier
- Download full text (pdf) of VLDLR mediates Semliki Forest virus neuroinvasion through the blood-cerebrospinal fluid barrier
-
Tailoring vascular phenotype through AAV therapy promotes anti-tumor immunity in glioma
Part of Cancer Cell, p. 1134-1151, 2023
- DOI for Tailoring vascular phenotype through AAV therapy promotes anti-tumor immunity in glioma
- Download full text (pdf) of Tailoring vascular phenotype through AAV therapy promotes anti-tumor immunity in glioma
-
Part of Clinical Cancer Research, p. 4139-4152, 2023
- DOI for Single-Cell RNA Analysis Reveals Cell-Intrinsic Functions of CAR T Cells Correlating with Response in a Phase II Study of Lymphoma Patients
- Download full text (pdf) of Single-Cell RNA Analysis Reveals Cell-Intrinsic Functions of CAR T Cells Correlating with Response in a Phase II Study of Lymphoma Patients
-
Complementarity-determining region clustering may cause CAR-T cell dysfunction
Part of Nature Communications, 2023
- DOI for Complementarity-determining region clustering may cause CAR-T cell dysfunction
- Download full text (pdf) of Complementarity-determining region clustering may cause CAR-T cell dysfunction
-
Ixovex-1, a novel oncolytic E1B-mutated adenovirus
Part of Cancer Gene Therapy, p. 1628-1635, 2022
- DOI for Ixovex-1, a novel oncolytic E1B-mutated adenovirus
- Download full text (pdf) of Ixovex-1, a novel oncolytic E1B-mutated adenovirus
-
Part of Nature Biomedical Engineering, p. 830-841, 2022
- DOI for CAR T cells expressing a bacterial virulence factor trigger potent bystander antitumour responses in solid cancers
- Download full text (pdf) of CAR T cells expressing a bacterial virulence factor trigger potent bystander antitumour responses in solid cancers
-
Part of Nature Communications, 2021
- DOI for Agonistic CD40 therapy induces tertiary lymphoid structures but impairs responses to checkpoint blockade in glioma
- Download full text (pdf) of Agonistic CD40 therapy induces tertiary lymphoid structures but impairs responses to checkpoint blockade in glioma
-
Part of Neuro-Oncology, p. 398-411, 2021
- DOI for ELTD1-deletion reduces vascular abnormality and improves T-cell recruitment after PD-1 blockade in glioma.
- Download full text (pdf) of ELTD1-deletion reduces vascular abnormality and improves T-cell recruitment after PD-1 blockade in glioma.
-
Part of MOLECULAR THERAPY-ONCOLYTICS, p. 356-366, 2021
- DOI for Concurrent expression of HP-NAP enhances antitumor efficacy of oncolytic vaccinia virus but not for Semliki Forest virus
- Download full text (pdf) of Concurrent expression of HP-NAP enhances antitumor efficacy of oncolytic vaccinia virus but not for Semliki Forest virus
-
Part of MOLECULAR THERAPY-ONCOLYTICS, p. 37-46, 2021
- DOI for IFN-I-tolerant oncolytic Semliki Forest virus in combination with anti-PD1 enhances T cell response against mouse glioma
- Download full text (pdf) of IFN-I-tolerant oncolytic Semliki Forest virus in combination with anti-PD1 enhances T cell response against mouse glioma
-
Part of Cell Death and Disease, 2020
- DOI for Characterization of virus-mediated immunogenic cancer cell death and the consequences for oncolytic virus-based immunotherapy of cancer
- Download full text (pdf) of Characterization of virus-mediated immunogenic cancer cell death and the consequences for oncolytic virus-based immunotherapy of cancer
-
Part of Oncoimmunology, 2020
- DOI for Tumor endothelial cell up-regulation of IDO1 is an immunosuppressive feed-back mechanism that reduces the response to CD40-stimulating immunotherapy
- Download full text (pdf) of Tumor endothelial cell up-regulation of IDO1 is an immunosuppressive feed-back mechanism that reduces the response to CD40-stimulating immunotherapy
-
Part of Oncoimmunology, 2018
-
Part of Oncoimmunology, 2018
- DOI for Cancer vaccine based on a combination of an infection-enhanced adenoviral vector and pro-inflammatory allogeneic DCs leads to sustained antigen-specific immune responses in three melanoma models
- Download full text (pdf) of Cancer vaccine based on a combination of an infection-enhanced adenoviral vector and pro-inflammatory allogeneic DCs leads to sustained antigen-specific immune responses in three melanoma models
-
Part of Clinical Cancer Research, p. 1519-1530, 2017
-
Part of Scandinavian Journal of Immunology, p. 341-341, 2017
-
Part of MOLECULAR THERAPY-ONCOLYTICS, p. 67-75, 2017
- DOI for Insertion of the Type-I IFN Decoy Receptor B18R in a miRNA-Tagged Semliki Forest Virus Improves Oncolytic Capacity but Results in Neurotoxicity
- Download full text (pdf) of Insertion of the Type-I IFN Decoy Receptor B18R in a miRNA-Tagged Semliki Forest Virus Improves Oncolytic Capacity but Results in Neurotoxicity
-
Part of Molecular Therapy, p. 288-288, 2017
-
Long-term episomal gene transfer for safe engineering of T cells for adoptive cell therapy of cancer
Part of CANCER IMMUNOLOGY RESEARCH, 2016
-
Part of EMBO Molecular Medicine, p. 702-711, 2016
- DOI for Safe engineering of CAR T cells for adoptive cell therapy of cancer using long-term episomal gene transfer
- Download full text (pdf) of Safe engineering of CAR T cells for adoptive cell therapy of cancer using long-term episomal gene transfer
-
Long-term episomal gene transfer for safe engineering of T-cells for adoptive cell therapy of cancer
Part of Human Gene Therapy, 2014
-
Part of BMC Cancer, p. 30, 2014
- DOI for Systemic treatment with CAR-engineered T cells against PSCA delays subcutaneous tumor growth and prolongs survival of mice
- Download full text (pdf) of Systemic treatment with CAR-engineered T cells against PSCA delays subcutaneous tumor growth and prolongs survival of mice
-
Part of Molecular Therapy, 2014
-
Part of Journal of Immunology, p. 2287-2296, 2014
-
Part of Molecular Therapy, p. 2008-2018, 2013
- DOI for An infection-enhanced oncolytic adenovirus secreting H. pylori neutrophil-activating protein with therapeutic effects on neuroendocrine tumors
- Download full text (pdf) of An infection-enhanced oncolytic adenovirus secreting H. pylori neutrophil-activating protein with therapeutic effects on neuroendocrine tumors
-
Part of PLOS ONE, 2013
- DOI for Adenovirus Serotype 5 Vectors with Tat-PTD Modified Hexon and Serotype 35 Fiber Show Greatly Enhanced Transduction Capacity of Primary Cell Cultures
- Download full text (pdf) of Adenovirus Serotype 5 Vectors with Tat-PTD Modified Hexon and Serotype 35 Fiber Show Greatly Enhanced Transduction Capacity of Primary Cell Cultures
Articles, review/survey
-
Of mice and lymphoid aggregates: modeling tertiary lymphoid structures in cancer
Part of Frontiers in Immunology, 2023
- DOI for Of mice and lymphoid aggregates: modeling tertiary lymphoid structures in cancer
- Download full text (pdf) of Of mice and lymphoid aggregates: modeling tertiary lymphoid structures in cancer
-
Tertiary Lymphoid Structures in the Central Nervous System: Implications for Glioblastoma
Part of Frontiers in Immunology, 2021
- DOI for Tertiary Lymphoid Structures in the Central Nervous System: Implications for Glioblastoma
- Download full text (pdf) of Tertiary Lymphoid Structures in the Central Nervous System: Implications for Glioblastoma
-
Tumor angiogenesis: causes, consequences, challenges and opportunities
Part of Cellular and Molecular Life Sciences (CMLS), p. 1745-1770, 2020
- DOI for Tumor angiogenesis: causes, consequences, challenges and opportunities
- Download full text (pdf) of Tumor angiogenesis: causes, consequences, challenges and opportunities
-
Part of Seminars in Cancer Biology, p. 23-35, 2017
- DOI for The cancer-immunity cycle as rational design for synthetic cancer drugs: Novel DC vaccines and CAR T-cells
- Download full text (pdf) of The cancer-immunity cycle as rational design for synthetic cancer drugs: Novel DC vaccines and CAR T-cells
Chapters in book
-
Immunotherapy for Neuroendocrine Neoplasms
Part of Neuroendocrine Tumours, p. 665-676, Springer Nature, 2024